ClinicalTrialStartPulse: 100+
500 clinicalTrialStartPulse: 100+ are listed from ClinicalTrials.gov (U.S. National Library of Medicine) API v2, dated 2026-10-07 to 2026-11-02; the most frequent is AstraZeneca with 32. Data last updated 2026-11-03; each record links to its official source and a full report.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
Includes: Sponsor, Phase, Conditions, Enrollment, Countries, Event, Posted, official source URL and score · Card, Apple Pay, Google Pay or Link via Stripe
500 records from ClinicalTrials.gov (U.S. National Library of Medicine) API v2, dated 2026-10-07 to 2026-11-02. Most frequent: AstraZeneca (32). Each record links to a full report and the official source.
Last updated 2026-11-03. Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Get new ClinicalTrialStartPulse records by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
- AstraZeneca (32)
- Pfizer (24)
- Merck Sharp & Dohme LLC (15)
- Hoffmann-La Roche (15)
- Sanofi (13)
How do I get new clinicalTrialStartPulse: 100+ by email?
Search, filter and export these records, or get alerts when new ones appear.
What are the top clinicalTrialStartPulse: 100+ right now?
| Record | Phase | Conditions | Enrollment |
|---|---|---|---|
| TriGemX Bio, Inc. | Phase 3 | Migraine | 1500 |
| Vertanical GmbH | Phase 3 | Lumbosacral Radiculopathy | 810 |
| Sanofi | Phase 2 | Ulcerative Colitis | 105 |
| Merck Sharp & Dohme LLC | Phase 3 | Hyperlipidemia; Hypercholesterolemia | 150 |
| Guangzhou Patronus Biotech Co., Ltd. | Phase 3 | Respiratory Syncytial Virus (RSV); Respiratory Syncytial Virus (RSV) Infection; RSV Vaccine | 25000 |
| Merck Sharp & Dohme LLC | Phase 3 | Small Cell Lung Cancer | 564 |
| Keymed Biosciences Co.Ltd | Phase 3 | Multiple Myeloma (MM) | 320 |
| Merck Sharp & Dohme LLC | Phase 2 | Metastatic Castration-resistant Prostate Cancer | 290 |
| AstraZeneca | Phase 3 | Large B-cell Lymphoma | 1200 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | Phase 3 | Advanced or Metastatic NSCLC | 206 |
| Xilio Development, Inc. | Phase 2 | Metastatic NSCLC - Non-Small Cell Lung Cancer; Advanced Solid Tumor | 180 |
| Vaxcyte, Inc. | Phase 3 | Pneumococcal Disease | 1390 |
| Genmab | Phase 3 | Head and Neck Squamous Cell Carcinoma | 699 |
| AstraZeneca | Phase 2 | Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer; Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer | 477 |
| Genmab | Phase 3 | Head and Neck Squamous Cell Carcinoma | 621 |
| Sanofi | 🔒 Unlock all 500 records → | ||
| ArriVent BioPharma, Inc. | 🔒 Unlock all 500 records → | ||
| AstraZeneca | 🔒 Unlock all 500 records → | ||
Browse 35 more matching record reports
- Sanofi
- ArriVent BioPharma, Inc.
- AstraZeneca
- Innovent Biologics (Suzhou) Co. Ltd.
- Pfizer
- Hoffmann-La Roche
- Bristol-Myers Squibb
- Idorsia Pharmaceuticals Ltd.
- LuciLab
- Merck Sharp & Dohme LLC
- EyeBiotech Ltd.
- Viatris Innovation GmbH
- Viatris Innovation GmbH
- Janssen Research & Development, LLC
- Pelage Pharmaceuticals, Inc.
- Qilu Pharmaceutical Co., Ltd.
- 35Pharma Inc., a GSK company
- Pfizer
- DualityBio Inc.
- BeiGene
- atai Therapeutics, Inc.
- Merck Sharp & Dohme LLC
- AbbVie
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Janssen Research & Development, LLC
- Jade Biosciences, Inc.
- Kite, A Gilead Company
- Shanghai Mabgeek Biotech.Co.Ltd
- Hoffmann-La Roche
- AstraZeneca
- MedTrace Pharma A/S
- NS Pharma, Inc.
- Hoffmann-La Roche
- BioNTech SE
- AstraZeneca
Which related categories and locations should I check?
Browse by phase
Not applicable (device, behavioral) (4211) Observational (1999) Phase 2 (1077) Phase 3 (559) Phase 1 (546) Phase 4 (320) Early phase 1 (89)
Browse by site location
Outside the US only (6377) United States sites (2424)
Browse by minimum enrollment
50+ (283) 300+ (96) 1,000+ (54)
Frequently asked questions
How many clinicalTrialStartPulse: 100+ are listed?
500 records from ClinicalTrials.gov (U.S. National Library of Medicine) API v2, last refreshed automatically. The most recent is dated 2026-11-02.
Can I get alerts for 100+?
Yes. ClinicalTrialStartPulse can email you new records matching this filter; plans are listed on the ClinicalTrialStartPulse page.
Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2. Informational only. RSS feed of new records